Fig. 5.
Comparative performance of urine and serum biomarkers in pancreatic cancer. Paired sera and urines obtained from 55 patients diagnosed with pancreatic ductal adenocarcinoma and 44 patients diagnosed with a spectrum of benign pancreatic conditions were evaluated using Luminex multiplexed immunoassays for 20 biomarkers. Biomarker level distributions in urine and serum are presented along with ROC curves and AUC values (solid line: urine; dashed line: serum).